SCHEMBL7087597

SCHEMBL7087597

Cc1cc(CCBr)n(O)c(=O)c1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 19/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11822962 0.86 IDH1 (0.62) IDH1
SCHEMBL7094059 0.83 IDH1 (0.59) IDH1
SCHEMBL7089306 0.80 IDH1 (0.65) IDH1
SCHEMBL10726805 0.79 IDH1 (0.54) IDH1
SCHEMBL7087767 0.79 IDH1 (0.54) IDH1
SCHEMBL7087631 0.79 IDH1 (0.54) IDH1
SCHEMBL10934346 0.79 IDH1 (0.54) IDH1
SCHEMBL11856342 0.79 IDH1 (0.54) IDH1
SCHEMBL7091685 0.78 IDH1 (0.62) IDH1
SCHEMBL3131899 0.78 IDH1 (0.53) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030228340-A1 Methods for treating rosacea with pyridones MEDICIS PHARMACEUTICAL CORPORATION 2003-12-11 US disclosed
WO-2003084538-A1 METHODS FOR TREATING ROSACEA WITH PYRIDONES MEDICIS PHARMACEUTICAL CORPORATION (US) 2003-10-16 WO disclosed